Skip to main content

Advertisement

SpringerLink
Log in

Socioeconomic Barriers to CRS HIPEC for Appendiceal Cancer within a Regional Academic Hospital System

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Appendiceal cancer with peritoneal metastases (ACPM) is a complex disease requiring multidisciplinary care. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can significantly improve survival but requires evaluation by a surgical oncologist and significant treatment endurance. The impacts of socioeconomic status (SES) and other social determinants of health on rates of surgical evaluation and treatment have not been examined.

Methods

We conducted a retrospective cohort study examining all patients with ACPM from 2010 to 2018 in a regional healthcare system. Patient characteristics, oncologic details, treatment strategies, and survival were examined. The primary outcomes of interest were referral to Surgical Oncology, receipt of CRS HIPEC, and survival.

Results

Of 194 patients identified, 94% had synchronous ACPM. The majority of patients (95%) were referred to surgical oncology. Advanced age was the only predictor of nonreferral (p < 0.001). A total of 147 patients (76%) ultimately underwent CRS HIPEC. After adjusting for medical and tumor characteristics, CRS HIPEC was less likely for patients who were unmarried [odds ratio (OR) 0.253, p = 0.004] or of low SES (OR 0.372, p = 0.03). On subanalysis of patients undergoing CRS HIPEC, median overall survival was worse for patients of low SES [51 months versus not reached (NR), p = 0.05], and this disparity persisted on multivariate analysis [hazard ratio (HR) = 2.278, p = 0.001].

Conclusions

This analysis is the first to evaluate barriers to CRS HIPEC for ACPM. While most patients were evaluated by a multidisciplinary team, nonmedical factors may play a role in the treatment received and ultimate outcomes. Addressing these disparities is crucial for ensuring equitable outcomes and improving patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Kirkegård J, Ladekarl M, Fristrup CW, Hansen CP, Sall M, Mortensen FV. Urban versus rural residency and pancreatic cancer survival: a Danish nationwide population-based cohort study. PLoS One. 2018;13(8):e0202486. https://doi.org/10.1371/journal.pone.0202486.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lee RM, Liu Y, Gamboa AC, et al. Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: what is driving disparities in receipt of treatment? J Surg Oncol. 2019;120(4):611–23. https://doi.org/10.1002/jso.25632.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lutfi W, Zenati MS, Zureikat AH, Zeh HJ, Hogg ME. Health disparities impact expected treatment of pancreatic ductal adenocarcinoma nationally. Ann Surg Oncol. 2018;25(7):1860–7. https://doi.org/10.1245/s10434-018-6487-5.

    Article  PubMed  Google Scholar 

  4. Shapiro M, Chen Q, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic xancer. JAMA Surg. 2016;151(4):338–45. https://doi.org/10.1001/jamasurg.2015.4239.

    Article  PubMed  Google Scholar 

  5. Hoehn RS, Rieser CJ, Winters S, et al. A pancreatic cancer multidisciplinary clinic eliminates socioeconomic disparities in treatment and improves survival. Ann Surg Oncol. Feb 1 2021;doi:https://doi.org/10.1245/s10434-021-09594-8.

  6. Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL. Size and importance of socioeconomic status-based disparities in use of surgery in nonadvanced stage gastrointestinal cancers.

  7. van Roest MH, van der Aa MA, van der Geest LG, de Jong KP. The impact of socioeconomic status, surgical resection and type of hospital on survival in patients with pancreatic cancer. A population-based study in the Netherlands. PLoS One. 2016;11(11):e0166449. doi:https://doi.org/10.1371/journal.pone.0166449.

  8. Rieser CJ, Hoehn RS, Zenati M, et al. Impact of socioeconomic status on presentation and outcomes in colorectal peritoneal metastases following cytoreduction and chemoperfusion: persistent inequalities in outcomes at a high-volume center. Ann Surg Oncol. Mar 9 2021;doi:https://doi.org/10.1245/s10434-021-09627-2.

  9. Miura J, Karakousis G. Improving access to specialized centers is not enough to mitigate socioeconomic disparities in complex oncologic surgery. Ann Surg Oncol. Feb 6 2021;doi:https://doi.org/10.1245/s10434-021-09631-6.

  10. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51. https://doi.org/10.1016/0895-4356(94)90129-5.

    Article  CAS  PubMed  Google Scholar 

  11. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon’s role. Langenbecks Arch Surg. 1999;384(6):576–87. https://doi.org/10.1007/s004230050246.

    Article  CAS  PubMed  Google Scholar 

  12. Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1–7. https://doi.org/10.1097/SLA.0b013e318296c732.

    Article  PubMed  Google Scholar 

  13. Health UoWSoMaP. Area Deprivation Index 2.0. Downloaded from https://www.neighborhoodatlas.medicine.wisc.edu/ (accessed 3/1/2021).

  14. Mora J, Krepline AN, Aldakkak M, et al. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. Am J Surg. Dec 3 2020;doi:https://doi.org/10.1016/j.amjsurg.2020.12.001.

  15. Arias F, Chen F, Fong TG, et al. Neighborhood-level social disadvantage and risk of delirium following major surgery. J Am Geriatr Soc. 2020;68(12):2863–71. https://doi.org/10.1111/jgs.16782.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL. Size and importance of socioeconomic status-based disparities in use of surgery in nonadvanced stage gastrointestinal cancers. Ann Surg Oncol. 2020;27(2):333–41. https://doi.org/10.1245/s10434-019-07922-7.

    Article  PubMed  Google Scholar 

  17. Tohme S, Kaltenmeier C, Bou-Samra P, Varley PR, Tsung A. Race and health disparities in patient refusal of surgery for early-stage pancreatic cancer: an NCDB cohort study. Ann Surg Oncol. 2018;25(12):3427–35. https://doi.org/10.1245/s10434-018-6680-6.

    Article  PubMed  Google Scholar 

  18. Kaltenmeier C, Malik J, Yazdani H, et al. Refusal of cancer-directed treatment by colon cancer patients: risk factors and survival outcomes. Am J Surg. 2020;220(6):1605–12. https://doi.org/10.1016/j.amjsurg.2020.04.022.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Votanopoulos KI, Bartlett D, Moran B, et al. PCI is not predictive of survival after complete CRS/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol. 2018;25(3):674–8. https://doi.org/10.1245/s10434-017-6315-3.

    Article  PubMed  Google Scholar 

  20. Levinsky NC, Morris MC, Wima K, et al. Should we be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC Collaborative. J Gastrointest Surg. 2020;24(1):155–64. https://doi.org/10.1007/s11605-019-04336-4.

    Article  PubMed  Google Scholar 

  21. Munoz-Zuluaga CA, King MC, Diaz-Sarmiento VS, et al. Defining “complete cytoreduction” after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for the histopathologic spectrum of appendiceal carcinomatosis. Ann Surg Oncol. 2020;27(13):5026–36. https://doi.org/10.1245/s10434-020-08844-5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number T32CA113263. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Caroline Rieser MD, MS, Amer Zureikat MD, James Pingpank MD, Melanie Ongchin MD, Andrew Lee MD & M. Haroon Choudry MD

  2. Division of Trauma and Acute Care Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Heather Phelos MPH & Joshua Brown MD, MS

  3. Division of Surgical Oncology, University Hospitals, Cleveland, OH, USA

    Richard S. Hoehn MD

Authors
  1. Caroline Rieser MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heather Phelos MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amer Zureikat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Pingpank MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melanie Ongchin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrew Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joshua Brown MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Haroon Choudry MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Richard S. Hoehn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard S. Hoehn MD.

Ethics declarations

Disclosure

There are no conflicts of interest for the authors of this manuscript.

Data Sharing and Data Accessibility

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

Ethical Approval Statement

This study was approved by our institutional review board (IRB20100475).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 1 (DOCX 21 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rieser, C., Phelos, H., Zureikat, A. et al. Socioeconomic Barriers to CRS HIPEC for Appendiceal Cancer within a Regional Academic Hospital System. Ann Surg Oncol 29, 6593–6602 (2022). https://doi.org/10.1245/s10434-022-11949-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11949-8

Search

Navigation